Meet with top Israeli leaders at the Jerusalem Post Annual Conference 2017
BIRD Foundation invests $5.4m. in Israel-US projects
December 21, 2010 05:33
6 projects approved by the foundation’s board of governors add to the more than 800 projects in which the Foundation has invested.
The Jerusalem Post

Money 311. (photo credit:Bloomberg)

The Israel-US Binational Industrial Research and Development (BIRD) Foundation on Tuesday announced the approval of $5.4 million of funding for six new projects between Israeli and American companies in the fields of communications, health-care information technology and personalized medicine.

“The approved projects reflect a trend in demand for personalization with the help of information technology in various fields such as health-care services and entertainment,” BIRD Foundation CEO Eitan Yudilevich said. “There is high demand for technology that enables the easy exchange of large quantities of information.”

Be the first to know - Join our Facebook page.

Export leaders honored at Beit Hanassi
Your Investments: Take charge of your retirement

The combined budget for the joint projects will be $15m., including the grants from the BIRD Foundation and additional private-sector funding.

The six projects approved by the foundation’s board of governors add to the more than 800 projects in which the BIRD Foundation has invested over its 33-year history.

To date, BIRD’s total investment in these projects has exceeded $280m., helping to generate direct and indirect sales of more than $8 billion.

Among the approved projects are the development of an automated medicine- pill dispensing system for home care by Israeli firm Vaica Medical and US firm MTS Medication. Israel’s First Life and US firm Healthline Networks will develop a health-care website consolidating drug effectiveness and patients’ experience data.

The BIRD Foundation promotes collaboration between Israeli and American companies in various technological fields for the purpose of joint product development. It assists by locating strategic partners from each country, making the necessary introductions and providing conditional grants of up to $1m. for approved projects.

The foundation supports projects without receiving any rights in the participating companies or in the project itself. The financial assistance is repaid as royalties from sales.

The foundation provides support of up to 50 percent of a project’s budget, beginning with R&D and ending with the initial stages of sales and marketing.
Relevant to your professional network? Please share on Linkedin

  • health
  • business
  • finance
  • investment
  • Share this article via
    from around the web
    Related Content
    The Teva Pharmaceutical Industries
    April 30, 2015
    Teva doubles down on Mylan, despite rejection


    Top Stories
    Israel Weather
    • 10 - 24
      Beer Sheva
      11 - 19
      Tel Aviv - Yafo
    • 12 - 21
      10 - 20
    • 16 - 30
      11 - 25